NYSE$AORT
Artivion Inc · Q4 2024 earnings
Q4 2024 earnings · · After market close · Investor relations
Briefing
Artivion reported its financial results for the fourth quarter and full year ended December 31, 2024.
Artivion reported a 4% increase in revenue on a GAAP basis for Q4 2024, reaching $97.3 million, and a 10% increase for the full year 2024, reaching $388.5 million. The company achieved positive free cash flow and significant growth in adjusted EBITDA, while also making strides in clinical and regulatory initiatives, including receiving Humanitarian Device Exemption for AMDS.
- Fourth quarter 2024 revenue increased by 4% on a GAAP basis to $97.3 million compared to $93.7 million in Q4 2023.
- Full year 2024 revenue increased by 10% on a GAAP basis to $388.5 million compared to $354.0 million in 2023.
- Adjusted EBITDA increased by 15% to $17.6 million in Q4 2024 and by 32% to $71.3 million for the full year 2024.
- Net loss for Q4 2024 was $(16.5) million, or $(0.39) per fully diluted share, while non-GAAP net income was $0.2 million, or $0.00 per fully diluted share.
Headline financials
Revenue & EPS history
Artivion · Revenue · Quarterly
$97.3M
Revenue by segment
Artivion · $13.7M total across 1 segment · Q4 2020
- On-X$13.7M+2.4%100.0%
Forward guidance
Artivion expects revenues for the full year 2025 to be in the range of $420 million to $435 million, representing growth of 10% to 14% on a constant currency basis compared to 2024. Adjusted EBITDA growth is expected to be between 18% and 28% for the full year 2025 compared to 2024, resulting in an expected range of $84 million to $91 million for 2025.
Tailwinds
- Expected revenue growth of 10% to 14% on a constant currency basis for full year 2025.
- Anticipated adjusted EBITDA growth of 18% to 28% for full year 2025.
- Continued confidence in executing on best-in-class pipeline.
- Driving sustained double-digit revenue growth.
- Adjusted EBITDA growth at twice the pace of constant currency revenue growth.
Headwinds
- Expected negative currency impact of approximately 2% on year-over-year reported revenue growth rates in 2025.
- The company's financial performance for 2025 and future periods is subject to identified risks.
- Unpredictability of the timing and outcome of regulatory decisions.
- Risks relating to international operations.
- Uncertainty regarding potential unknown or future impacts of the November 2024 cybersecurity incident.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
+1.0%
Avg return
Earnings day
+1.1%
Avg return
5 days after
+3.3%
Avg return
30 days after
52%
33 / 64 earnings
Positive
+23.5%
Q1 2021
Best reaction
-15.7%
Q4 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.8% | -36.8% | -43.2% | |
| Q3 2025 | -5.9% | +0.3% | -6.1% | |
| Q1 2025 | +14.9% | +21.6% | +22.5% | |
| Q4 2024 | -8.2% | -8.8% | -12.0% | |
| Q3 2024 | -2.5% | -5.8% | +0.7% | |
| Q2 2024 | -1.2% | -0.3% | -0.2% | |
| Q1 2024 | +13.6% | +12.4% | +12.0% | |
| Q4 2023 | +7.1% | +6.5% | +12.5% | |
| Q3 2023 | +10.5% | +7.1% | +40.6% | |
| Q2 2023 | -3.3% | -1.7% | +1.9% | |
| Q1 2023 | +12.7% | +9.1% | +13.4% | |
| Q4 2022 | +4.3% | -1.5% | -11.7% | |
| Q3 2022 | -1.9% | -3.2% | +18.7% | |
| Q2 2022 | -1.8% | -1.2% | -3.9% | |
| Q1 2022 | -11.4% | -21.6% | -12.4% | |
| Q4 2021 | -0.1% | -1.7% | +22.4% | |
| Q3 2021 | +4.3% | +2.6% | -16.1% | |
| Q2 2021 | +1.3% | +1.2% | -2.6% | |
| Q1 2021 | +23.5% | +21.1% | +22.0% | |
| Q4 2020 | +0.8% | +1.1% | +1.3% | |
| Q3 2020 | -4.9% | +10.5% | +17.1% | |
| Q2 2020 | +1.6% | +4.7% | +7.3% | |
| Q1 2020 | -4.0% | -2.0% | -1.6% | |
| Q4 2019 | -8.1% | -9.3% | -27.2% | |
| Q3 2019 | -7.7% | -3.4% | +1.7% | |
| Q2 2019 | -4.6% | -6.3% | -11.4% | |
| Q1 2019 | +2.1% | +4.0% | -5.5% | |
| Q4 2018 | -15.2% | -4.6% | +0.1% | |
| Q3 2018 | -4.7% | -1.1% | -3.3% | |
| Q2 2018 | +9.4% | +10.1% | +15.9% | |
| Q1 2018 | +6.2% | +12.3% | +22.9% | |
| Q4 2017 | +12.8% | +9.9% | +0.8% | |
| Q3 2017 | -2.7% | -4.8% | +1.8% | |
| Q2 2017 | +3.1% | -1.3% | -1.6% | |
| Q1 2017 | +13.2% | +12.6% | +12.3% | |
| Q4 2016 | -15.7% | -9.7% | -11.5% | |
| Q3 2016 | -1.5% | +0.0% | +18.2% | |
| Q2 2016 | +14.6% | +21.4% | +28.2% | |
| Q1 2016 | -1.8% | — | — | |
| Q4 2015 | +12.6% | — | — | |
| Q3 2015 | +11.1% | — | — | |
| Q2 2015 | -0.4% | — | — | |
| Q1 2015 | +4.0% | — | — | |
| Q4 2014 | -4.2% | — | — | |
| Q3 2014 | -6.1% | — | — | |
| Q2 2014 | +6.4% | — | — | |
| Q1 2014 | -6.0% | — | — | |
| Q4 2013 | -9.1% | — | — | |
| Q3 2013 | +10.6% | — | — | |
| Q2 2013 | -5.4% | — | — | |
| Q1 2013 | -5.4% | — | — | |
| Q4 2012 | +2.0% | — | — | |
| Q3 2012 | +0.5% | — | — | |
| Q2 2012 | -4.3% | — | — | |
| Q1 2011 | +0.2% | — | — | |
| Q1 2012 | +5.1% | — | — | |
| Q4 2009 | -11.5% | — | — | |
| Q4 2011 | -11.5% | — | — | |
| Q3 2010 | +4.6% | — | — | |
| Q3 2011 | +4.6% | — | — | |
| Q2 2011 | +5.4% | — | — | |
| Q2 2010 | +5.4% | — | — | |
| Q4 2010 | +5.4% | — | — | |
| Q1 2010 | +3.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro